The Impact of Longitudinal Intestinal Lengthening and Tailoring on Liver Function in Short Bowel Syndrome

Abstract

Introduction: Short bowel syndrome is a functional or anatomic loss of major parts of the small bowel leading to severe malnutrition. The limiting factor for the survival of these patients remains parenteral nutrition-related liver damage leading to end-stage liver failure. Longitudinal intestinal lengthening and tailoring (LILT) has been proven to enhance peristalsis, to decrease bacterial overgrowth and to extend the mucosal contact time for the absorption of nutrients. The aim of this study was to show the impact of LILT on the development of parenteral nutrition-related liver damage. Patients and Methods: A cohort of 55 patients with short bowel syndrome managed with LILT in our institution between 1987 and 2007 was retrospectively reviewed. LILT was performed at a mean age of 24 months (range 4 – 150 months). Mean follow-up time was 83.76 months (range 5 – 240 months). We obtained reliable data from 31 patients with regard to liver enzymes and function parameters in blood samples before LILT and at the present time. Liver biopsy was performed in 14 patients prior to LILT. Results: Liver enzymes ALAT (mean 121 U/l), ASAT (mean 166 U/l) and bilirubin (mean 2.49 mg/dl) were elevated preoperatively in 27/31 children. After the lengthening procedure, ALAT (mean 50 U/l), ASAT (mean 63 U/l) and bilirubin (mean 1.059 mg/dl) normalized except in 5 of 8 patients who could not be weaned from parenteral nutrition after LILT. Liver function parameters such as the international normal ratio (INR) were slightly elevated in 5/31 patients. Albumin was generally low, probably due to parenteral nutrition. Liver biopsy was performed in 14 patients preoperatively, showing 4 patients with low-grade, 6 patients with intermediate and 4 patients with high-grade fibrosis. End-stage liver disease with cirrhosis was an exclusion criterion for LILT. All patients with liver fibrosis showed a normalization of liver enzymes when they were weaned from parenteral nutrition. But patients with higher grade liver fibrosis tend to develop more complications perioperatively. Conclusion: After LILT, all patients with liver fibrosis who could be weaned from parenteral nutrition showed a normalization of liver enzymes. Preoperative liver biopsy is mandatory in order to differentiate reversible liver fibrosis from end-stage liver disease. A higher grade of liver fibrosis and elevated INR has been shown to be a sensitive parameter for peri- and postoperative complications.

Key words

short bowel syndrome - intestinal lengthening - liver fibrosis

References

• 1 Bianchi A. Intestinal loop lengthening – a technique for increasing small intestinal length.  J Pediatr Surg. 1980;  15 145-151
• 2 Bianchi A. From the cradle to enteral autonomy: the role of autologous gastrointestinal reconstruction.  Gastroenterology. 2006;  130 138-146
• 3 Buchman A, Iyer K, Fryer J. Parenteral nutrition-associated liver disease and the role for isolated intestine and intestine/liver transplantation.  Hepatology. 2006;  43 9-19
• 4 Bueno J, Guiterrez J, Mazariegos G V. et al . Analysis of patients with longitudinal intestinal lengthening procedure referred for intestinal transplantation.  J Pediatr Surg. 2001;  36 178-183
• 5 Chang R W, Javid P J, Oh J T, Andreoli S, Kim H B, Fauza D, Jaksic T. Serial transverse enteroplasty enhances intestinal function in a model of short bowel syndrome.  Ann Surg. 2006;  243 223-228
• 6 Desmet V J. Cirrhosis: aetiology and pathogenesis: cholestasis. Boyer JL, Bianchi L Liver Cirrhosis. Lancaster; MTP Press 1987: 101-118
• 7 Desmet V J, Gerber M, Hoofnagle J H, Manns M, Scheuer P J. Classification of chronic hepatitis: diagnosis, grading and staging.  Hepatology. 1994;  19 1513-1520
• 8 Farnsworth N, Fagan S P, Berger D H, Awad S S. Child-Turcotte-Pugh versus MELD score as a predictor of outcome after elective and emergent surgery in cirrhotic patients.  Am J Surg. 2004;  188 580-583
• 9 Goulet O, Ruemmele F, Lacaille F, Colomb V. Irreversible intestinal failure.  J Pediatr Gastroenterol Nutr. 2004;  38 250-269
• 10 Goulet O, Ruemmele F. Causes and management of intestinal failure in children.  Gastroenterology. 2006;  130 16-28
• 11 Hosie S, Loff S, Wirth H, Rapp H J, von Buch C, Waag K L. Experience of 49 longitudinal intestinal lengthening procedures for short bowel syndrome.  Eur J Pediatr Surg. 2006;  16 171-175
• 12 Howard L, Ament M, Fleming C R, Shike M, Steiger E. Current use and clinical outcome of home parenteral and enteral nutrition therapies in the United States.  Gastroenterology. 1995;  109 355-365
• 13 Jeppesen P B, Staun M, Mortensen P B. Adult patients receiving home parenteral nutrition in Denmark from 1991 to 1996: who will benefit from intestinal transplantation?.  Scand J Gastroenterol. 1998;  33 839-846
• 14 Keegan M T, Plevak D J. Preoperative assessment of the patient with liver disease.  Am J Gastroenterol. 2005;  100 2116-2127
• 15 Kim H, Fauza D, Garza J, Oh J T, Nurko S, Jaksic T. Serial transverse enteroplasty (STEP): a novel bowel lengthening procedure.  J Pediatr Surg. 2003;  38 425-429
• 16 Messing B, Lemann M, Landais P, Gouttebel M C, Gerard-Boncompain M, Saudin F, Vangossum A, Beau P, Guedon C, Barnoud D. Prognosis of patients with nonmalignant chronic intestinal failure receiving long-term home parenteral nutrition.  Gastroenterology. 1995;  108 1005-1010
• 17 Modi B P, Javid P J, Jaksic T, Piper H, Langer M, Duggan C, Kamin D, Kim H B. International Step Data Registry. First report of the International Serial Transverse Enteroplasty Data Registry: indications, efficacy, and complications.  J Am Coll Surg. 2007;  204 365-371
• 18 Pironi L, Paganelli F, Labate A M, Merli C, Guidetti C, Spinucci G, Miglioli M. Safety and efficacy of home parenteral nutrition for chronic intestinal failure: a 16-year experience at a single centre.  Dig Liver Dis. 2003;  35 314-324
• 19 Reinshagen K, Kabs C, With H, Hable N, Brade J, Zahn K, Hagl C, Jester I, Waag K L. Long-term outcome of patients with short bowel syndrome after longitudinal intestinal lengthening and tailoring.  J Pediatr Gastroenterol Nutr. 2008; 
• 20 Sax H C, Talamini M A, Brackett K, Fischer J E. Hepatic steatosis in total parenteral nutrition: failure of fatty infiltration to correlate with abnormal serum hepatic enzyme levels.  Surgery. 1986;  100 697-704
• 21 Scolapio J S, Fleming C R, Kelly D G, Wick D M, Zinsmeister A R. Survival of home parenteral nutrition-treated patients: 20 years of experience at the Mayo Clinic.  Mayo Clin Proc. 1999;  74 217-222
• 22 Torres C, Sudan D, Vanderhoof J, Grant W, Botha J, Raynor S, Langnas A. Role of an intestinal rehabilitation program in the treatment of advanced intestinal failure.  J Pediatr Gastroenterol Nutr. 2007;  45 204-212
• 23 Tripodi A, Charantaranqkul V, Primiqnami M, Fabris F, DellÉra A, Sei C, Mannucci P M. The international normalized ratio calibrated for cirrhosis (INR(liver)) normalizes prothrombin time results for model for end-stage liver disease calculation.  Hepatology. 2007;  46 520-527
• 24 Wales P W, de Silva N, Kim J, Lecce L, To T, Moore A. Neonatal short bowel syndrome: population-based estimates of incidence and mortality rates.  J Pediatr Surg. 2004;  39 690-695
• 25 Wales P W, de Silva N, Kim J, Lecce L, Sandhu A, Moore A M. Neonatal short bowel syndrome: a cohort study.  J Pediatr Surg. 2005;  40 755-762
• 26 Weber T R, Powell M A. Early improvement in intestinal function after isoperistaltic bowel lengthening.  J Pediatr Surg. 1996;  31 61-64